The national surveillance protocol for invasive meningococcal disease (IMD) in England has been extended in recognition of:
Changes to the meningococcal group C (MCC) conjugate vacciination programme, including the removal of the infant MCC dose at 4 months and the introduction of an adolescent MCC dose in June 2013.
The emergency introduction of a quadrivalent conjugate vaccine against meningococcal groups A, C, W, and Y (MenACWY) for 14-18 year-olds in August 2015 in response to a national outbreak of a hypervirulent MenW.
The introduction of a MenB vaccine, Bexsero®, into the national infant immunisation schedule in September.
Local copy of Meningococcal_surveillance_plan_V1.pdf
Local copy of Meningococcal_surveillance_plan_V1.pdf
https://www.gov.uk/government/publications/meningococcal-disease-enhanced-surveillance-plan
seen at 11:41, 30 August in Publications on GOV.UK.Email this to a friend.